{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T14:07:35Z","timestamp":1749218855750,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T00:00:00Z","timestamp":1643414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health, Labor and Welfare Sciences Research Grants, Research for Promotion of Cancer Control Programs","award":["21EA1006"],"award-info":[{"award-number":["21EA1006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>The Japanese Society of Medical Oncology (JSMO) published a guideline (GL) on febrile neutropenia (FN) in 2017. This study aims to identify promoting factors and disincentives for complying with GL recommendations according to attributes of doctors providing chemotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A questionnaire survey was conducted with SurveyMonkey\u2122 for physician members of the Japanese Association of Supportive Care in Cancer and relevant academic organizations. Each question had four options (always do, do in more than half of patients, do in less than half, do not at all) and a free description form. Responses were analyzed according to the respondents\u2019 attributes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Result<\/jats:title>\n                <jats:p>Seven hundred eighty-eight out of retrieved 801 responses were available for analysis. Multivariable analysis demonstrated that the percentage of GL users was higher among women and Japanese Society of Clinical Oncology members. The overall compliance rate was higher among women, JSMO members, and board-certified medical oncologists. Internists emphasized the significance of collecting blood cultures at FN onset, and surgeons stressed the importance of G-CSF prophylaxis. Hematologists were less likely to adhere to recommendations on risk assessment of FN by the Multinational Association of Supportive Care in Cancer score and administration of gammaglobulin products. However, those are acceptable due to the characteristics of their practice. Eight recommendations had no difference in compliance rates between users and non-users, some of whose statements were ambiguous and discretionary.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Women were more likely to use and adhere to GL. The recommendations should be developed considering the characteristics of specialty and subspecialty and avoiding ambiguity and discretionary statements.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-022-06834-9","type":"journal-article","created":{"date-parts":[[2022,1,29]],"date-time":"2022-01-29T17:08:47Z","timestamp":1643476127000},"page":"4327-4336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Difference of compliance rates for the recommendations in Japanese Guideline on Febrile Neutropenia according to respondents\u2019 attributes: the second report on a questionnaire survey among hematology-oncology physicians and surgeons"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4840-6248","authenticated-orcid":false,"given":"Nobu","family":"Akiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuho","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minoru","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shun-ichi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Yano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isao","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kusaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosuke","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Iwasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Takamatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadamoto","family":"Zenda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,29]]},"reference":[{"key":"6834_CR1","doi-asserted-by":"publisher","unstructured":"Akiyama N, Okamura T, Yoshida M, et al (2021) A questionnaire survey on evaluation for prevention and compliance of the Japanese Guidelines on Febrile Neutropenia among hematology-oncology physicians and surgeons. Support Care Cancer 29: 6831-6839. https:\/\/doi.org\/10.1007\/s00520-021-06277-8.","DOI":"10.1007\/s00520-021-06277-8"},{"key":"6834_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00520-018-4481-x","volume":"27","author":"H Link","year":"2011","unstructured":"Link H, Kerkmann M, Holtmann L et al (2011) G-CSF guideline adherence in Germany an update with a retrospective and representative sample survey. Support Care in Cancer 27:1459\u20131469. https:\/\/doi.org\/10.1007\/s00520-018-4481-x","journal-title":"Support Care in Cancer"},{"key":"6834_CR3","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bmt.2012.244","volume":"48","author":"Y Kanda","year":"2013","unstructured":"Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48:452\u2013458. https:\/\/doi.org\/10.1038\/bmt.2012.244","journal-title":"Bone Marrow Transplant"},{"key":"6834_CR4","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1001\/jamainternmed.2016.7875","volume":"177","author":"Y Tsugawa","year":"2017","unstructured":"Tsugawa Y, Jena AB, Figueroa JF et al (2017) Comparison of hospital mortality and readmission rates for Medicare patients treated by male vs. female physicians. JAMA Intern Med 177:206\u2013213. https:\/\/doi.org\/10.1001\/jamainternmed.2016.7875","journal-title":"JAMA Intern Med"},{"key":"6834_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/eurjhf\/hfn041","volume":"11","author":"M Baumh\u00e4kel","year":"2009","unstructured":"Baumh\u00e4kel M, M\u00fcller U, B\u00f6hm M (2009) Influence of gender of physicians and patients on guideline-recommended treatment of chronic heart failure in a cross-sectional study. Eur J Heart Fail 11:299\u2013303. https:\/\/doi.org\/10.1093\/eurjhf\/hfn041","journal-title":"Eur J Heart Fail"},{"key":"6834_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ejca.20110.10.013","volume":"47","author":"MS Aapro","year":"2011","unstructured":"Aapro MS, Bohlius J, Cameron DA et al (2011) 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Eur J Cancer 47:8\u201332. https:\/\/doi.org\/10.1016\/j.ejca.20110.10.013","journal-title":"Eur J Cancer"},{"key":"6834_CR7","unstructured":"NCCN Guidelines Hematopoietic Growth Factors. Version 4.20211-May 20, 2021. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/growthfactors.pdf."},{"key":"6834_CR8","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1001\/jama.282.15.1458","volume":"282","author":"MD Cabana","year":"1999","unstructured":"Cabana MD, Rand SC, Powe NR et al (1999) Why don\u2019t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282:1458\u20131465. https:\/\/doi.org\/10.1001\/jama.282.15.1458","journal-title":"JAMA"},{"key":"6834_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s12185-020-02921-x","volume":"112","author":"S Kimura","year":"2020","unstructured":"Kimura S, Fujita H, Handa H et al (2020) Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group. Int J Hematol 112:409\u2013417. https:\/\/doi.org\/10.1007\/s12185-020-02921-x","journal-title":"Int J Hematol"},{"key":"6834_CR10","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.1007\/s00520-018-4292-0","volume":"26","author":"H Kato","year":"2018","unstructured":"Kato H, Fujita H, Akiyama N et al (2018) Infectious complications in adults undergoing intensive chemotherapy for acute myeloid leukemia in 2001\u20132005 using the Japan Adult Leukemia Study Group AML201 protocols. Support Care Cancer 26:4187\u20134198. https:\/\/doi.org\/10.1007\/s00520-018-4292-0","journal-title":"Support Care Cancer"},{"key":"6834_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12185-010-0746-y","volume":"93","author":"M Yoshida","year":"2011","unstructured":"Yoshida M, Akiyama N, Fujita H et al (2011) Analysis of bacteremia\/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group. Int J Hematol 93:66\u201373. https:\/\/doi.org\/10.1007\/s12185-010-0746-y","journal-title":"Int J Hematol"},{"key":"6834_CR12","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/S0140-6736(12)61763-2","volume":"381","author":"MJ Rummel","year":"2013","unstructured":"Rummel MJ, Niederle N, Maschmyer G et al (2013) Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomized, phase3 non-inferiority trial. Lancet 381:1203\u20131210. https:\/\/doi.org\/10.1016\/S0140-6736(12)61763-2","journal-title":"Lancet"},{"key":"6834_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.15761\/GIMCI.1000108","volume":"1","author":"A Pawlowicz","year":"2015","unstructured":"Pawlowicz A, Holland C, Zou B et al (2015) Implementation of an evidence-based algorithm reduces blood culture overuse in an adult emergency department. Gen Int Med Clin Innnov 1:20\u201325. https:\/\/doi.org\/10.15761\/GIMCI.1000108","journal-title":"Gen Int Med Clin Innnov"},{"key":"6834_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jemermed.2008.04.001","volume":"35","author":"NI Shapiro","year":"2008","unstructured":"Shapiro NI, Wolfe RE, Wright SB et al (2008) (2008) Who needs a blood culture? A prospectively derived and validated prediction rule. J Emerg Med 35:255\u2013264. https:\/\/doi.org\/10.1016\/j.jemermed.2008.04.001","journal-title":"J Emerg Med"},{"key":"6834_CR15","doi-asserted-by":"publisher","unstructured":"Mhaskar R, Clark OAC, Lyman G, et al (2014) Colony-stimulating factors for chemotherapy-induced febrile neutropenia. Cochrane Database Syst Rev. 2014:CD003039. https:\/\/doi.org\/10.1002\/14651858.CD003039.pub2.","DOI":"10.1002\/14651858.CD003039.pub2"},{"key":"6834_CR16","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/j.1440-1746.2010.06243.x","volume":"25","author":"JS Lubel","year":"2010","unstructured":"Lubel JS, Angus PW (2010) Hepatitis B reactivation in patients receiving cytotoxic chemotherapy: diagnosis and management. J Gastroenterol Hepatol 25:864\u2013871. https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06243.x","journal-title":"J Gastroenterol Hepatol"},{"key":"6834_CR17","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1515\/cclm-2015-0871","volume":"54","author":"JH Barth","year":"2016","unstructured":"Barth JH, Misra S, Aakre KM et al (2016) (2016) Why are clinical practice guidelines not followed? Clin Chem Lab Med 54:1133\u20131139. https:\/\/doi.org\/10.1515\/cclm-2015-0871","journal-title":"Clin Chem Lab Med"},{"key":"6834_CR18","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/bmj.317.7162.858","volume":"317","author":"R Grol","year":"1998","unstructured":"Grol R, Dalhuijsen J, Thomas S et al (1998) Attributes of clinical guidelines that influence use of guidelines in general practice: observational study. Brit Med J 317:858\u2013861. https:\/\/doi.org\/10.1136\/bmj.317.7162.858","journal-title":"Brit Med J"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-06834-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06834-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T07:17:17Z","timestamp":1648019837000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-06834-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,29]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["6834"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-06834-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"type":"print","value":"0941-4355"},{"type":"electronic","value":"1433-7339"}],"subject":[],"published":{"date-parts":[[2022,1,29]]},"assertion":[{"value":"20 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is not required to be reviewed by an ethical committee because it is designed as a questionnaire to doctors about the daily clinical practice on GL, and respondents voluntarily answered the questions on the website.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}